Notably, compared with NAFLD, though in a smaller but adequate statistical power- sample encompassing 4187 patients with chronic viral hepatitis, the rs58542926 had no effect on the circulating levels of ALT and AST. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.